# Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)

> **NCT00000488** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Myocardial Ischemia

## Interventions

- **DRUG:** cholestyramine
- **BEHAVIORAL:** diet, fat-restricted

## Key facts

- **NCT ID:** NCT00000488
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1973-06
- **Primary completion:** —
- **Final completion:** 1989-10
- **Target enrollment:** — (—)
- **Last updated:** 2016-04-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000488

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000488, "Lipid Research Clinics Coronary Primary Prevention Trial (CPPT)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00000488. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*